Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totaling 1,032 shares, a decline of 34.3% from the May 31st total of 1,571 shares. Based on an average trading volume of 609 shares, the short-interest ratio is currently 1.7 days. Currently, 0.0% of the shares of the stock are short sold.
Aspen Pharmacare Stock Performance
Shares of OTCMKTS APNHY opened at $9.41 on Thursday. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.64 and a quick ratio of 2.66. Aspen Pharmacare has a 12 month low of $5.24 and a 12 month high of $9.41. The stock has a 50-day moving average price of $8.66 and a two-hundred day moving average price of $7.80.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
